Atara Biotherapeutics Strengthens Board And Senior Management Team
4/8/2014 7:37:26 AM
Atara Biotherapeutics, Inc., a drug development company with a focus on innovative therapies for patients with debilitating diseases, announced today that it has strengthened its board of directors and executive team by appointing Matthew K. Fust as a director and hiring Mitchall G. Clark, B.Pharm, as chief regulatory and quality assurance officer.
Help employers find you! Check out all the jobs and post your resume.
comments powered by